Squarepoint’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-30,900
Closed -$3.04M 5000
2025
Q3
$3.04M Buy
30,900
+27,400
+783% +$2.72M ﹤0.01% 1772
2025
Q2
$319K Buy
+3,500
New +$338K ﹤0.01% 3638
2025
Q1
Sell
-2,700
Closed -$285K 5550
2024
Q4
$285K Buy
+2,700
New +$290K ﹤0.01% 4189
2023
Q2
Sell
-10,700
Closed -$1.38M 4089
2023
Q1
$1.38M Sell
10,700
-1,600
-13% -$201K 0.01% 1675
2022
Q4
$1.57M Buy
+12,300
New +$1.43M 0.01% 1511

Other funds holding ZBH

Squarepoint's ZBH Position: Q2 2026 in Review

Squarepoint reduced its Zimmer Biomet (ZBH) stake by 12% in Q2 2026, selling an estimated $459K and leaving 37,057 shares worth $3.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1962.

Squarepoint first reported a position in ZBH in Q1 2015 and has held it in 39 quarters since. The position peaked at $37.6M in Q2 2019. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Squarepoint held 37,057 shares of Zimmer Biomet worth $3.19M as of Q2 2026.
  • Squarepoint sold 5,236 Zimmer Biomet shares in Q2 2026, an estimated $459K.
  • Zimmer Biomet made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #1962 holding.
  • Squarepoint first reported a position in Zimmer Biomet in Q1 2015 and has held it in 39 quarters since.
  • Squarepoint's Zimmer Biomet position peaked at $37.6M in Q2 2019.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.